Accenture Announces Collaboration with Bayer to Streamline Drug Development Processes through INTIENT Clinical Platform

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites.
Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. For avoidance of any doubts and to make it easier, you may consider any links to external websites as sponsored links. Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Accenture (NYSE: ACN) has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve patient outcomes.

The Accenture INTIENT Clinical platform is part of Accenture INTIENT„¢ and builds upon Accentures market-proven platforms for research, clinical development, pharmacovigilance and patient services. It rapidly integrates new technology, advanced analytics and applied intelligence to support the delivery of patient treatments.

Bayer has also joined the Life Sciences Cloud Coalition, which was developed to enable pre-competitive collaboration between pharmaceutical companies with the goal to more quickly and cost-effectively advance clinical development. The coalition brings together Oracle Health Sciences and R&D leaders from around the world to drive innovation and digitally enable the R&D function.

Mike Stapleton, a managing director in Accentures Life Sciences practice, said: We are excited to work with Bayer to provide new insights on their clinical trials, so they can bring the important treatments they develop to patients faster and with the highest quality. The future of R&D is bright when leading organizations come together to solve for patients greatest needs.

The INTIENT Clinical platform was developed through an alliance between Accenture and Oracle. It combines Accentures proven implementation experience with solutions such as the Oracle Health Sciences Data Management Workbench and Oracle Life Sciences Data Hub. Together, these solutions generate high-quality, reliable data from clinical trials and reduce the time, effort and cost needed to take drugs from development to market. The Oracle solutions are powered by Oracle Cloud Infrastructure, supported with Oracle Managed Cloud Services.

We welcome Bayer as a new member of the Life Sciences Cloud Coalition and to the Oracle Health Sciences Data Management Workbench family. Their perspective and experience will be invaluable in the advancement of clinical development for the entire industry, said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences.

About Accenture

Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions underpinned by the worlds largest delivery network Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 469,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at


Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Lara Wozniak


+1 858 252 8208

[email protected]